ICP
RMD icon

Indus Capital Partners’s ResMed RMD Stock Holding History

Indus Capital Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-200,000
Closed -$9.85M – 43
2014
Q3 		$9.85M Sell
200,000
-150,000
-43% -$7.64M 0.97% 21
2014
Q2 		$17.7M Buy
+350,000
New +$17.3M 2.6% 12

Other funds holding RMD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Indus Capital Partners's RMD Position: Q4 2014 in Review

Indus Capital Partners sold out of ResMed (RMD) in Q4 2014, closing a stake of 200,000 shares — an estimated $9.85M sold.

Indus Capital Partners first reported a position in RMD in Q2 2014 and held it in 2 quarters. The position peaked at $17.7M in Q2 2014. 308 funds tracked by Wall St. Rank hold RMD as of Q4 2014.

  • Indus Capital Partners reported no remaining ResMed position as of Q4 2014 after selling out during the quarter.
  • Indus Capital Partners sold 200,000 ResMed shares in Q4 2014, an estimated $9.85M.
  • Indus Capital Partners first reported a position in ResMed in Q2 2014 and held it in 2 quarters.
  • Indus Capital Partners's ResMed position peaked at $17.7M in Q2 2014.
  • 308 funds tracked by Wall St. Rank held ResMed as of Q4 2014.

Based on Indus Capital Partners's 13F filing for Q4 2014, filed 12 Feb 2015.